ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Topical Thrombin Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30Z13880
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Topical Thrombin Market Research Report 2023
BUY CHAPTERS

Global Topical Thrombin Market Research Report 2025

Code: QYRE-Auto-30Z13880
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
CSL Limited
Hualan Biological
Haematologic Technologies
Pfizer Inc
OMRIX Biopharmaceuticals
Shanghai Raas
GE Healthcare
Grifols S A
Octapharma AG
Takeda

Topical Thrombin Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Topical Thrombin Market

Topical Thrombin Market

The global market for Topical Thrombin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Topical Thrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Thrombin.
The Topical Thrombin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Topical Thrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Thrombin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Topical Thrombin Market Report

Report Metric Details
Report Name Topical Thrombin Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Based Bovine
  • Based Human
  • Others
Segment by Application
  • Hospitals
  • Diagnostics & Clinics
  • Academic and Research Institute
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Topical Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Topical Thrombin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Topical Thrombin Market report?

Ans: The main players in the Topical Thrombin Market are Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS

What are the Application segmentation covered in the Topical Thrombin Market report?

Ans: The Applications covered in the Topical Thrombin Market report are Hospitals, Diagnostics & Clinics, Academic and Research Institute

What are the Type segmentation covered in the Topical Thrombin Market report?

Ans: The Types covered in the Topical Thrombin Market report are Based Bovine, Based Human, Others

Recommended Reports

Hemostatic Devices

Coagulation Testing

Hemostatic Consumables

1 Topical Thrombin Market Overview
1.1 Product Definition
1.2 Topical Thrombin by Type
1.2.1 Global Topical Thrombin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Based Bovine
1.2.3 Based Human
1.2.4 Others
1.3 Topical Thrombin by Application
1.3.1 Global Topical Thrombin Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Topical Thrombin Market Size Estimates and Forecasts
1.4.1 Global Topical Thrombin Revenue 2020-2031
1.4.2 Global Topical Thrombin Sales 2020-2031
1.4.3 Global Topical Thrombin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Topical Thrombin Market Competition by Manufacturers
2.1 Global Topical Thrombin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Topical Thrombin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Topical Thrombin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Topical Thrombin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Topical Thrombin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Topical Thrombin, Product Type & Application
2.7 Global Key Manufacturers of Topical Thrombin, Date of Enter into This Industry
2.8 Global Topical Thrombin Market Competitive Situation and Trends
2.8.1 Global Topical Thrombin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Topical Thrombin Players Market Share by Revenue
2.8.3 Global Topical Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Topical Thrombin Market Scenario by Region
3.1 Global Topical Thrombin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Topical Thrombin Sales by Region: 2020-2031
3.2.1 Global Topical Thrombin Sales by Region: 2020-2025
3.2.2 Global Topical Thrombin Sales by Region: 2026-2031
3.3 Global Topical Thrombin Revenue by Region: 2020-2031
3.3.1 Global Topical Thrombin Revenue by Region: 2020-2025
3.3.2 Global Topical Thrombin Revenue by Region: 2026-2031
3.4 North America Topical Thrombin Market Facts & Figures by Country
3.4.1 North America Topical Thrombin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Topical Thrombin Sales by Country (2020-2031)
3.4.3 North America Topical Thrombin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Topical Thrombin Market Facts & Figures by Country
3.5.1 Europe Topical Thrombin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Topical Thrombin Sales by Country (2020-2031)
3.5.3 Europe Topical Thrombin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Thrombin Market Facts & Figures by Region
3.6.1 Asia Pacific Topical Thrombin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Topical Thrombin Sales by Region (2020-2031)
3.6.3 Asia Pacific Topical Thrombin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Topical Thrombin Market Facts & Figures by Country
3.7.1 Latin America Topical Thrombin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Topical Thrombin Sales by Country (2020-2031)
3.7.3 Latin America Topical Thrombin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Topical Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Thrombin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Topical Thrombin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Topical Thrombin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Topical Thrombin Sales by Type (2020-2031)
4.1.1 Global Topical Thrombin Sales by Type (2020-2025)
4.1.2 Global Topical Thrombin Sales by Type (2026-2031)
4.1.3 Global Topical Thrombin Sales Market Share by Type (2020-2031)
4.2 Global Topical Thrombin Revenue by Type (2020-2031)
4.2.1 Global Topical Thrombin Revenue by Type (2020-2025)
4.2.2 Global Topical Thrombin Revenue by Type (2026-2031)
4.2.3 Global Topical Thrombin Revenue Market Share by Type (2020-2031)
4.3 Global Topical Thrombin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Topical Thrombin Sales by Application (2020-2031)
5.1.1 Global Topical Thrombin Sales by Application (2020-2025)
5.1.2 Global Topical Thrombin Sales by Application (2026-2031)
5.1.3 Global Topical Thrombin Sales Market Share by Application (2020-2031)
5.2 Global Topical Thrombin Revenue by Application (2020-2031)
5.2.1 Global Topical Thrombin Revenue by Application (2020-2025)
5.2.2 Global Topical Thrombin Revenue by Application (2026-2031)
5.2.3 Global Topical Thrombin Revenue Market Share by Application (2020-2031)
5.3 Global Topical Thrombin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Topical Thrombin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Topical Thrombin Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Topical Thrombin Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Grifols Topical Thrombin Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Company Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GE Healthcare Topical Thrombin Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Company Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Biological Topical Thrombin Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies
6.7.1 Haematologic Technologies Company Information
6.7.2 Haematologic Technologies Description and Business Overview
6.7.3 Haematologic Technologies Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Haematologic Technologies Topical Thrombin Product Portfolio
6.7.5 Haematologic Technologies Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Topical Thrombin Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Octapharma Topical Thrombin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals
6.10.1 Omrix Biopharmaceuticals Company Information
6.10.2 Omrix Biopharmaceuticals Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Omrix Biopharmaceuticals Topical Thrombin Product Portfolio
6.10.5 Omrix Biopharmaceuticals Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Company Information
6.11.2 Shanghai RAAS Description and Business Overview
6.11.3 Shanghai RAAS Topical Thrombin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai RAAS Topical Thrombin Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Thrombin Industry Chain Analysis
7.2 Topical Thrombin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Thrombin Production Mode & Process Analysis
7.4 Topical Thrombin Sales and Marketing
7.4.1 Topical Thrombin Sales Channels
7.4.2 Topical Thrombin Distributors
7.5 Topical Thrombin Customer Analysis
8 Topical Thrombin Market Dynamics
8.1 Topical Thrombin Industry Trends
8.2 Topical Thrombin Market Drivers
8.3 Topical Thrombin Market Challenges
8.4 Topical Thrombin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
CSL Limited
Hualan Biological
Haematologic Technologies
Pfizer Inc
OMRIX Biopharmaceuticals
Shanghai Raas
GE Healthcare
Grifols S A
Octapharma AG
Takeda
List of Tables
 Table 1. Global Topical Thrombin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Topical Thrombin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Topical Thrombin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Topical Thrombin Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Topical Thrombin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Topical Thrombin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Topical Thrombin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Topical Thrombin Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Topical Thrombin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Topical Thrombin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Topical Thrombin, Product Type & Application
 Table 12. Global Key Manufacturers of Topical Thrombin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Topical Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Thrombin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Topical Thrombin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Topical Thrombin Sales by Region (2020-2025) & (Tons)
 Table 18. Global Topical Thrombin Sales Market Share by Region (2020-2025)
 Table 19. Global Topical Thrombin Sales by Region (2026-2031) & (Tons)
 Table 20. Global Topical Thrombin Sales Market Share by Region (2026-2031)
 Table 21. Global Topical Thrombin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Topical Thrombin Revenue Market Share by Region (2020-2025)
 Table 23. Global Topical Thrombin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Topical Thrombin Revenue Market Share by Region (2026-2031)
 Table 25. North America Topical Thrombin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Topical Thrombin Sales by Country (2020-2025) & (Tons)
 Table 27. North America Topical Thrombin Sales by Country (2026-2031) & (Tons)
 Table 28. North America Topical Thrombin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Topical Thrombin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Topical Thrombin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Topical Thrombin Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Topical Thrombin Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Topical Thrombin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Topical Thrombin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Topical Thrombin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Topical Thrombin Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Topical Thrombin Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Topical Thrombin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Topical Thrombin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Topical Thrombin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Topical Thrombin Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Topical Thrombin Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Topical Thrombin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Topical Thrombin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Topical Thrombin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Topical Thrombin Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Topical Thrombin Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Topical Thrombin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Topical Thrombin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Topical Thrombin Sales (Tons) by Type (2020-2025)
 Table 51. Global Topical Thrombin Sales (Tons) by Type (2026-2031)
 Table 52. Global Topical Thrombin Sales Market Share by Type (2020-2025)
 Table 53. Global Topical Thrombin Sales Market Share by Type (2026-2031)
 Table 54. Global Topical Thrombin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Topical Thrombin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Topical Thrombin Revenue Market Share by Type (2020-2025)
 Table 57. Global Topical Thrombin Revenue Market Share by Type (2026-2031)
 Table 58. Global Topical Thrombin Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Topical Thrombin Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Topical Thrombin Sales (Tons) by Application (2020-2025)
 Table 61. Global Topical Thrombin Sales (Tons) by Application (2026-2031)
 Table 62. Global Topical Thrombin Sales Market Share by Application (2020-2025)
 Table 63. Global Topical Thrombin Sales Market Share by Application (2026-2031)
 Table 64. Global Topical Thrombin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Topical Thrombin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Topical Thrombin Revenue Market Share by Application (2020-2025)
 Table 67. Global Topical Thrombin Revenue Market Share by Application (2026-2031)
 Table 68. Global Topical Thrombin Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Topical Thrombin Price (US$/Kg) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Takeda Topical Thrombin Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Bayer Topical Thrombin Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. CSL Topical Thrombin Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Grifols Company Information
 Table 86. Grifols Description and Business Overview
 Table 87. Grifols Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Grifols Topical Thrombin Product
 Table 89. Grifols Recent Developments/Updates
 Table 90. GE Healthcare Company Information
 Table 91. GE Healthcare Description and Business Overview
 Table 92. GE Healthcare Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. GE Healthcare Topical Thrombin Product
 Table 94. GE Healthcare Recent Developments/Updates
 Table 95. Hualan Biological Company Information
 Table 96. Hualan Biological Description and Business Overview
 Table 97. Hualan Biological Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Hualan Biological Topical Thrombin Product
 Table 99. Hualan Biological Recent Developments/Updates
 Table 100. Haematologic Technologies Company Information
 Table 101. Haematologic Technologies Description and Business Overview
 Table 102. Haematologic Technologies Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Haematologic Technologies Topical Thrombin Product
 Table 104. Haematologic Technologies Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Pfizer Topical Thrombin Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Octapharma Company Information
 Table 111. Octapharma Description and Business Overview
 Table 112. Octapharma Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Octapharma Topical Thrombin Product
 Table 114. Octapharma Recent Developments/Updates
 Table 115. Omrix Biopharmaceuticals Company Information
 Table 116. Omrix Biopharmaceuticals Description and Business Overview
 Table 117. Omrix Biopharmaceuticals Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Omrix Biopharmaceuticals Topical Thrombin Product
 Table 119. Omrix Biopharmaceuticals Recent Developments/Updates
 Table 120. Shanghai RAAS Company Information
 Table 121. Shanghai RAAS Description and Business Overview
 Table 122. Shanghai RAAS Topical Thrombin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Shanghai RAAS Topical Thrombin Product
 Table 124. Shanghai RAAS Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Topical Thrombin Distributors List
 Table 128. Topical Thrombin Customers List
 Table 129. Topical Thrombin Market Trends
 Table 130. Topical Thrombin Market Drivers
 Table 131. Topical Thrombin Market Challenges
 Table 132. Topical Thrombin Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Topical Thrombin
 Figure 2. Global Topical Thrombin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Topical Thrombin Market Share by Type: 2024 & 2031
 Figure 4. Based Bovine Product Picture
 Figure 5. Based Human Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Topical Thrombin Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Topical Thrombin Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Diagnostics & Clinics
 Figure 11. Academic and Research Institute
 Figure 12. Global Topical Thrombin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Topical Thrombin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Topical Thrombin Sales (2020-2031) & (Tons)
 Figure 15. Global Topical Thrombin Average Price (US$/Kg) & (2020-2031)
 Figure 16. Topical Thrombin Report Years Considered
 Figure 17. Topical Thrombin Sales Share by Manufacturers in 2024
 Figure 18. Global Topical Thrombin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Topical Thrombin Players: Market Share by Revenue in Topical Thrombin in 2024
 Figure 20. Topical Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Topical Thrombin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Topical Thrombin Sales Market Share by Country (2020-2031)
 Figure 23. North America Topical Thrombin Revenue Market Share by Country (2020-2031)
 Figure 24. United States Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Topical Thrombin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Topical Thrombin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Topical Thrombin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Topical Thrombin Revenue Market Share by Region (2020-2031)
 Figure 35. China Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Topical Thrombin Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Topical Thrombin Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Topical Thrombin Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Topical Thrombin Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Topical Thrombin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Topical Thrombin by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Topical Thrombin by Type (2020-2031)
 Figure 54. Global Topical Thrombin Price (US$/Kg) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Topical Thrombin by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Topical Thrombin by Application (2020-2031)
 Figure 57. Global Topical Thrombin Price (US$/Kg) by Application (2020-2031)
 Figure 58. Topical Thrombin Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Thrombin Human Market Research Report 2025
Topical Absorbable Hemostats Market
Global Thrombin Preparation Market Research Report 2024
Finished Dosage Form Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Haemostatic Sponge Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostasis Clips Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Antithrombin III Market Research Report 2024
Hemostatic Sponge Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Recombinant Thrombin Market Research Report 2024
Global Haemostat Market Research Report 2025
Thrombectomy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coagulase Plasma Market Research Report 2025
Collagen Hemostatic Sponge Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostatic Matrix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombocytes Market Research Report 2025
Deep Vein Thrombosis DVT Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atherectomy and Thromboctomy Devices Market Research Report 2025
Global Anticoagulation Therapy Devices Market Research Report 2024
Clotting Factor Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions